Acute Cholecystitis Market to Grow with Advancing Healthcare Industry During the Forecast Period
Changing
lifestyles and eating habits are driving the growth in Global Acute
Cholecystitis Market in the forecast period, 2023-2027.
According to TechSci Research report, “Acute
Cholecystitis Market - Global Industry Size,
Share, Trends, Opportunity and Forecast, 2017-2027”, the global acute cholecystitis market may potentially project an
impressive growth in the forecast period, 2023-2027, with an impressive CAGR on
the account of rising instances of patients suffering from the gall bladder
stone conditions. The accumulation of compound materials like calcium
carbonate, palmitate phosphate, bilirubin, and other bile pigment causes the
acute cholecystitis problems.
The geriatric population is highly affected of the condition due to
their weak gastro-intestinal tract and weaker digestive system. The rising
geriatric population is also supporting the growth of the global acute
cholecystitis market in the upcoming five years. Moreover, healthcare industry
is consistently involved in advanced research and technological developments.
This has provided the patients with earlier diagnostics, efficient treatment,
and effective prolonging results that confirmatively driving the growth of the market.
Additionally, change in the eating habits of the population is
increasing the chances of them developing the condition and thus anticipated to
drive the growth of the market in the next five years. Young population is
inclined heavily toward snack and fast food which has adverse effects on the
health and thus making the population more prone to developing the condition.
According to recent research reports, more than 20% young population in the
United States suffer from gallstones that further leads to cholecystitis.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Acute Cholecystitis Market"
https://www.techsciresearch.com/report/acute-cholecystitis-market/9316.html
The global acute cholecystitis market is segmented
by type, cause, diagnostic procedure, treatment, end user, regional
distribution, and competitional landscape. Based on cause, the market is
differentiated into gall bladder stones, tumor, bile duct blockage, microbial
infection, and others. Gall bladder stones are the major and most presumptuous
cause of acute cholecystitis.
Due to unhealthy eating habits and weaker digestive
systems, the accumulation of calcium derivatives in the gall bladder is very
prominent. These factors are supporting the fact that gall bladder stones are
the most possible cause of acute cholecystitis. Moreover, the increasing
instances of gastro-intestinal cancer and tumors are also increasing and are
major cause behind the increased cases of acute cholecystitis in the upcoming
five years.
Based on type, the market is further divided
between calculous acute cholecystitis and acalculous acute cholecystitis.
Depending on the obstruction site the acute cholecystitis is of two types.
Acute cholecystitis is a medical condition where stone-like obstructions are
accumulated in the gallbladder, or the gastro-intestinal tube that connects
gallbladder to the small intestine.
If the obstruction is at the gall bladder duct it
is termed as calculous acute cholecystitis and if the obstruction is at any
other site in the gall bladder or the tube, it is termed as acalculous acute
cholecystitis. Calculous acute cholecystitis is a worse condition of gall
bladder condition and requires immediate attention thereby is anticipated to
hold the larger market revenue shares and assert its dominance over the market
segment. Acalculous acute cholecystitis is also an emergency situation but is
comparatively less painful and may register significant growth in the market
shares in the next five years.
Holding the major shares of the global acute
cholecystitis market are:
·
Boston
Scientific Corporation
·
Fresenius
Kabi AG
·
Pfizer
Inc
·
Teva
Pharmaceutical Industries Ltd.
·
Glenmark
Pharmaceuticals Limited
·
Merck
& Co., Inc.
·
Becton,
Dickinson and Company
·
Simulab
Corporation
·
AbbVie,
Inc.
·
Fortimedix
Surgical BV
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=9316
Customers can also request for 10% free customization on this report.
“North America regionally supports the best healthcare industry
in the world. Economies like United States, Canada has the most versatile and
developed healthcare sector and are anticipated to support the claim of North
America being the most promising region for the market growth in the future
five years. United States even has a large population suffering from the
condition and aiding the growth of the market. Asia Pacific region is expected
to register fastest growing market and fastest CAGR rate in the next five
years. The countries in the region like India, China, and Japan, are
consistently evolving and advancing their healthcare sector. With evolved
pharmaceutical sector, and better treatment possibilities along with the
affordable rates of the treatment and diagnosis, the region is bound to be an
advantageous section for the new market players. New market entrants must
invest in research and technological advancements for the future endeavors,”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based Global management consulting firm.
“Global
Acute Cholecystitis Market By Type (Calculous Acute Cholecystitis v/s
Acalculous Acute Cholecystitis) By Cause (Gall Bladder Stones, Tumor, Bile Duct
Blockage, Microbial Infection, Others) By Diagnostic Procedure (Ultrasonography,
Cholescintigraphy, CT Scan, ERCP (Endoscopic Retrograde
Cholangiopancreatography), Others) By Treatment (Surgical v/s Non-Surgical) By
End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) By
Region, Competition Forecast & Opportunities, 2027”, has evaluated the future growth
potential of global acute cholecystitis and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global acute cholecystitis market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/